Maximum quantity allowed is 999
请选择数量
CAS RN: 54350-48-0 | 產品號碼: E1293
| 產品號碼 | E1293 |
| 純度/分析方法 | >98.0%(HPLC) |
| 分子式 / 分子量 | C__2__3H__3__0O__3 = 354.49 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
| 包裝和容器 | 250MG-Glass Bottle with Plastic Insert （閲覽圖片）, 50MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 54350-48-0 |
| Reaxys-RN | 2225606 |
| PubChem Substance ID | 468591705 |
| Merck Index(14) | 3892 |
| MDL編號 | MFCD00866624 |
產品規格
| Appearance | White to Yellow to Green powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 103.0 to 107.0 °C |
性質
| 熔點 | 105 °C |
| Maximum Wavelength | 360 nm (H__2O) |
| 水溶性 | Insoluble |
| 溶解性（可溶於） | Ether, Acetone |
GHS
| 圖形表示 |
|
| 信號詞 | Danger |
| 危險性說明 | H315 : Causes skin irritation. H319 : Causes serious eye irritation. H360 : May damage fertility or the unborn child. H410 : Very toxic to aquatic life with long lasting effects. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P391 : Collect spillage. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P405 : Store locked up. |
相關法規
| RTECS # | RA6620000 |
運輸資料
| UN編號 | UN3077 |
| 類別 | 9 |
| 包裝類別 | III |
| HS編碼* | 2918.99-000 |
Application
Etretinate: A Synthetic Retinoic Acid Derivative that is a Prodrug of Acitretin
Etretinate is a retinoic acid (vitamin A acid) [R0064] derivative that is a prodrug of acitretin [A3097]. Etretinate is used for the treatment of severe psoriasis and other dyskeratoses, but the precise mechanism of action of it is not fully understood. However, the pharmacological profile of etretinate suggests that it acts by normalizing pathological changes in epidermal and dermal skin, particularly inhibiting hyperkeratinization and cell differentiation. In addition, etretinate reportedly has teratogenic potential. (The product is for research purpose only.)
References
- Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders (a review)
- Recent progress in commercial retinoids and carotenoids (a review)
- Modulations of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells
- Comparative teratogenicity of nine retinoids in the rat
- Determination of isotretinoin or etretinate and their major metabolites in human blood by reversed-phase high-performance liquid chromatography
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。